SGMO

SGMO Earnings Preview

Sangamo Therapeutics, Inc. · Healthcare · $83M

8d until earnings

SGMO Earnings

Monday, May 11 2026
EPS Estimate
$-0.07
$-0.09 – $-0.05
Revenue Estimate
$34M
Current Price
$0.14

Data Signal Summary

1 bullish
3 bearish
Estimates down -75% Put/call 0.3 (bullish skew) Price downtrend Insider selling

Key Context

Insider Activity
selling
Price Trend
downtrend
From 52w High
-46.1%
Est. Revisions (30d)
-75.0% 0up/1dn
Analyst Target (mean)
$4 $1–$10 +2579%
Options P/C Ratio
0.32
Est. Dispersion
57% 2 analysts
Fund Convergence
strong Renaissance, Two Sigma, Citadel

Recent Activity

insider trades 15 transactions
Sell · DAVIS GREGORY D (Officer) ·69,827 shares ·$17,694
Sell · DUBOIS-STRINGFELLOW NATHALIE (Officer) ·345,942 shares ·$89,184
Award · BEERS COURTNEY (Director) ·25,000 shares
Award · MARKELS JOHN (Director) ·25,000 shares
Award · HORN MARGARET A (Director) ·25,000 shares
10 more
Award · PARKER H STEWART ·25,000 shr
Award · MEYERS JAMES ROBERT ·25,000 shr
Award · CAREY ROBERT F. ·25,000 shr
Award · HILLAN KENNETH J. ·25,000 shr
Award · SMITH KAREN LESLEY M.D. PH.D. ·25,000 shr
Award · MACRAE SANDY ·375,000 shr
Award · DURAIBABU PRATHYUSHA ·120,000 shr
Award · WILLOUGHBY SCOTT B ·120,000 shr
Award · DUBOIS-STRINGFELLOW NATHALIE ·120,000 shr
Award · DAVIS GREGORY D ·49,726 shr